1、August 2019 Consumer Subscription Software Insights 2 Consumer Subscription Software (“CSS”) Insights CSS CEO Commentary Investor Interest in CSS is Growing About GP Bullhound 1 2 3 4 Confidential 3 Consumer Software Perspectives Executive Summary GP Bullhound is a leading technology advisory and in

2、vestment firm, providing transaction advice and capital to category leaders with a robust focus on Enterprise however, they have not been independently verified and are not guaranteed as being accurate. The information contained in this research report is not intended to be a complete statement or s

3、ummary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by GP Bullhound LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness o

4、r reliability of the information in this research report nor should it be relied upon as such. This research report may contain forward-looking statements, which involve risks and uncertainties. Forward-looking information is provided for illustrative purposes only and is not intended to serve as, a

5、nd must not be relied upon as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Any and all opinions expressed are current opinions as of the date appearing

6、 on the documents included in this research report. Any and all opinions expressed are subject to change without notice and GP Bullhound LLP is under no obligation to update the information contained in this research report. Disclaimer The information contained in this research report should not be

7、relied upon as being an independent or impartial view of the subject matter and for the purposes of the rules and guidance of the Financial Conduct Authority (“the FCA”) this research report is a marketing communication and a financial promotion. Accordingly, its contents have not been prepared in a

8、ccordance with legal requirements designed to promote the independence of investment research and it is not subject to any prohibition on dealing ahead of the dissemination of investment research. The individuals who prepared the information contained in this research report may be involved in provi

9、ding other financial services to the company or companies referenced in this research report or to other companies who might be said to be competitors of the company or companies referenced in this research report. As a result, both GP Bullhound LLP and the individual members, directors, officers an

10、d/ or employees who prepared the information contained in this research report may have responsibilities that conflict with the interests of the persons who access this research report. GP Bullhound LLP and/or connected persons may, from time-to-time, have positions in, make a market in and/or effec

11、t transactions in any investment or related investment mentioned in this research report and may provide financial services to the issuers of such investments. The information contained in this research report or any copy of part thereof should not be accessed by a person in any jurisdictions where

12、its access may be restricted by law and persons into whose possession the information in this research report comes should inform themselves about, and observe, any such restrictions. Access of the information contained in this research report in any such jurisdictions may constitute a violation of

13、UK or US securities law, or the law of any such other jurisdictions. Neither the whole nor any part of the information contained in this research report may be duplicated in any form or by any means. Neither should the information contained in this research report, or any part thereof, be redistribu

14、ted or disclosed to anyone without the prior consent of GP Bullhound LLP. GP Bullhound LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in the information contained in this res

15、earch report. Accordingly, information may be available to GP Bullhound LLP that is not reflected in this material and GP Bullhound LLP may have acted upon or used the information prior to or immediately following its publication. In addition, GP Bullhound LLP, the members, directors, officers and/o

16、r employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this research report and may from time-to-time add or dispose of such interests. GP Bullhound LLP is a

17、 limited liability partnerhip registered in England and Wales, registered number OC352636, and is authorised and regulated by the Financial Conduct Authority. Any reference to a partner in relation to GP Bullhound LLP is to a member of GP Bullhound LLP or an employee with equivalent standing and qua

18、lifications. A list of the members of GP Bullhound LLP is available for inspection at its registered office, 52 Jermyn Street, London SW1Y 6LX. For US Persons: This research report is distributed to U.S. persons by GP Bullhound Inc. a broker- dealer registered with the SEC and a member of the FINRA.

19、 GP Bullhound Inc. is an affiliate of GP Bullhound LLP. This research report does not provide personalized advice or recommendations of any kind. All investments bear certain material risks that should be considered in consultation with an investors financial, legal and tax advisors. GP Bullhound In

20、c. engages in private placement and mergers and acquisitions advisory activities with clients and counterparties in the Technology and CleanTech sectors. In the last twelve months, GP Bullhound LLP and its affiliates have been engaged as an advisor to and received compensation from Signavio, Appbudd

21、y, Mambu, Zugata, Falcon.io, Synthesio, Rant & Rave, Alltrails, Extenda. LONDON tel. +44 207 101 7560 52 Jermyn Street London, SW1Y 6LX United Kingdom SAN FRANCISCO tel. +1 415 986 0191 One Sansome Street, Suite 3650 San Francisco, CA 94104 USA STOCKHOLM tel. +46 8 545 074 14 Grev Turegatan 30 Stock

22、holm, 114 38 Sweden BERLIN tel. +49 30 610 80 600 Kleine Jaegerstr. 8 Berlin, 101 17 Germany PARIS tel. +33 1 82 88 43 40 45 rue de Lisbonne 75 008 Paris France MANCHESTER tel. +44 161 413 5030 1 New York Street Manchester, M1 4HD United Kingdom HONG KONG tel. +852 5806 1310 Level 6, Champion Tower 3 Garden Road, Central Hong Kong MADRID tel. +34 951 12 72 32 Paseo de Recoletos 6 28001 Madrid Spain NEW YORK tel. +1 212 759 1870 489 Fifth Avenue, 34thPH New York, NY 10017 USA